Experiences with Atazanavir cobicistat | HealthUnlocked

2 public posts

Gilead Announces Phase 3 Results for Genvoya® (Elvitegravir, Cobicistat, etc.), an Investigational Once-Daily Single Tablet Regimen for HIV

http://www.natap.org/2015/EACS/EACS_01.htm

http://www.natap.org/2015/EACS/EACS_01.htm

in HFI Connect - Hepatitis

FDA Approves Two Combination Therapies for HIV

Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR

Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg cobicistat (a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR

in HFI Connect - Hepatitis

Want to take advantage of all our features? Just log in!

or